CLINICAL_TRIALS trial_result · 2020-06-11

Clinical Trial Update: A Study of AG-348 in Adult Participants With Pyruvate Kinase (PK) Deficiency [Phase 2]

Phase 2 study of AG-348 (mitapivat) in adults with pyruvate kinase deficiency has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Agios Pharmaceuticals, Inc. | Conditions: Pyruvate Kinase Deficiency | Phase 2 | Status: COMPLETED | Results posted: 2020-06-11